AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company markets Feraheme (ferumoxytol) and MuGard Mucoadhesive Oral Wound Rinse. Feraheme Injection for Intravenous (IV) is indicated for the treatment of iron deficiency anemia in adult patients with CKD. The Company offers Feraheme to both the dialysis and non-dialysis CKD markets, including to nephrologists, hematologists, dialysis organizations, hospitals and other end-users who treat patients with CKD. MuGard is indicated for the management of oral mucositis/stomatitis and all types of oral wounds (mouth sores and injuries). Lumara Health, Inc. (Lumara Health), a division of AMAG Pharmaceuticals, is dedicated to advancing women�s health. Lumara Health is the exclusive marketer of Makena (hydroxyprogesterone caproate injection), a FDA-approved product indicated to reduce the risk of pre-term birth in women who are pregnant with one baby and who have delivered one pre-term baby spontaneously in the past.